An observational study to assess persistence on treatment, adherence, and patient-reported outcomes during the treatment of chronic hepatitis C genotype 1 infected patients with Boceprevir added to Peginterferon plus Ribavirin in Italy (MK-3034-137)

21/03/2014
02/04/2024
EU PAS number:
EUPAS6019
Study
Finalised
Documents
Study protocol
Study results
Study results
English (186.31 KB - PDF) View document
Study report
Other information